when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Sanofi ($SNY) · news · pharmadog

← back to Sanofi

News mentioning $SNY

221 stories

Jul 29, 26Caldera, Vidya add to recent flurry of biotech mergersbiopharma dive

Jul 29, 26AbCellera, Vertex partner on next-gen T-cell engagersbiopharma dive

Jul 29, 267 companies hiring in New York nowbiospace

Jul 29, 26Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, morebiospace

Jul 28, 26Eli Lilly tops new biopharma ranking on launch success, development speedfiercebiotech

Jul 28, 26STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATDstat

Jul 24, 26Sanofi halts development of troubled immune drug in eczemabiopharma dive

Jul 24, 26Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrappedbiospace

Jul 24, 26Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotechbiospace

Jul 24, 26STAT+: Fatal gene-editing trial in China raises ethics and oversight questionsstat

Jul 24, 26STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and morestat

Jul 24, 26A new, separate outbreak of the diarrhea-causing parasitestat

Jul 24, 26Sanofi nixes Kymab-originated OX40L antibody in atopic dermatitisendpoints

Jul 24, 26Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyoutfiercebiotech

Jul 24, 26Scribe records upsized $129M IPO to bankroll lipid-lowering genetic medsfiercebiotech

Jul 23, 26Chutes & Ladders—Biogen R&D vet gets in Formationfiercebiotech

Jul 23, 26STAT+: Popular insulin product enters shortage as other pens leave marketstat

Jul 22, 266 companies hiring in Cambridge nowbiospace

Jul 22, 26FDA issues untitled letters to Sanofi and Viatris for false advertisingraps

Jul 20, 26Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic medsfiercebiotech

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 17, 26Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advancesbiopharma dive

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 16, 26Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patentsendpoints

Jul 15, 26J&J dips despite upbeat outlook; AstraZeneca, Spero cut China dealsbiopharma dive

Jul 15, 26STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and morestat

Jul 14, 26STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded accessstat

Jul 14, 26STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last yearstat

Jul 14, 26STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and morestat

Jul 13, 26STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patentsstat

← prevpage 5 of 8next →